Down-regulation of PKCzeta in renal cell carcinoma and its clinicopathological ... - 7thSpace Interactive (press release) PDF Print
7thSpace Interactive (press release)
Metastatic renal cell carcinoma (RCC) is highly resistant to systemic chemotherapy. Unfortunately, nearly all patients die of the metastatic and chemoresistant RCC. Recent studies have shown the atypical PKCzeta is an important regulator of

...

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.